Please provide your email address to receive an email when new articles are posted on . Mycobacterial infections of the foot and ankle are rare among patients with diabetic foot infections. No ...

Nontuberculous mycobacteria (NTM) are known as atypical mycobacteria. That means they’re related to tuberculosis, but they don’t cause the same disease. In fact, NTM are generally harmless. That’s a ...

Patients with rheumatic disease are at a higher risk of infection than the general population. Studies have focused mainly on the infection risk associated with the treatment of rheumatic disease. 1 ...

Tedizolid Phosphate Viable for Bacterial Skin Infections Nontuberculous mycobacterial infection can occur after fractionated carbon dioxide (CO2) laser resurfacing. (HealthDay News) – Nontuberculous ...

A team of United States-based scientists recently conducted a study to evaluate the effect of Mycobacterium tuberculosis infection on the pathogenesis of severe acute respiratory syndrome coronavirus ...

The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial ...

Please provide your email address to receive an email when new articles are posted on . Establishing several firsts, a hospital in London used genetically engineered bacteriophages to successfully ...

An Australian study has linked rapidly growing mycobacterium infections to gastric banding surgery, but no clear source has been identified, according to an article published online September 10 in ...

Mycobacterium avium complex (MAC), a type of nontuberculous mycobacteria (NTM), lives all around us. You’ll find these germs in dirt, dust, and drinking water. They’re also common in natural sources ...

Reviews of Infectious Diseases, Vol. 11, Supplement 2. Research towards Global Control and Prevention of Tuberculosis with an Emphasis on Vaccine Development (Mar. - Apr., 1989), pp. S394-S399 (6 ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.